Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
72 USD | -6.12% | +5.93% | +0.53% |
Apr. 18 | Intra-Cellular Therapies Prices $500 Million Stock Offering | MT |
Apr. 17 | Goldman Sachs Adjusts Price Target on Intra-Cellular Therapies to $77 From $67, Maintains Neutral Rating | MT |
- Stock Market
- Equities
- ITCI Stock
- News Intra-Cellular Therapies, Inc.